Peripheral vascular disease, erectile dysfunction, cardiovascular disease, dementia and memory issues, kidney disease and exercise performance are all areas where L-carnitine holds potential as a therapeutic agent
And in short that came out a few years after that STEP 1 trial what we did for the very first time is take individuals with obesity and pre-existing cardiovascular disease, like a prior stroke, prior heart attack, or peripheral arterial disease, called PAD, and they're on maximal therapy for their cardiovascular disease or stroke, and then randomized them on top of that to either semaglutide or placebo
In particular, we frequently use the TruMed Myers in Fatigue, Anxiety and Depression and Athletic performance on an extremely regular basis
What Are the Negative Side Effects of GLP-1
Personalized care